Vita Life Sciences Limited (ASX:VLS)
1.815
+0.065 (3.71%)
Apr 30, 2025, 10:50 AM AEST
Vita Life Sciences Ratios and Metrics
Market cap in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 29, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Market Capitalization | 100 | 111 | 96 | 77 | 105 | 54 | Upgrade
|
Market Cap Growth | 16.19% | 16.19% | 25.14% | -26.95% | 93.88% | 45.21% | Upgrade
|
Enterprise Value | 72 | 84 | 77 | 62 | 89 | 43 | Upgrade
|
Last Close Price | 1.81 | 1.93 | 1.65 | 1.21 | 1.65 | 0.83 | Upgrade
|
PE Ratio | 11.49 | 12.68 | 10.56 | 10.81 | 12.65 | 8.88 | Upgrade
|
Forward PE | - | 16.81 | 16.81 | 16.81 | 16.81 | 16.81 | Upgrade
|
PS Ratio | 1.26 | 1.40 | 1.31 | 1.15 | 1.84 | 1.16 | Upgrade
|
PB Ratio | 1.92 | 2.13 | 2.21 | 2.10 | 3.45 | 2.21 | Upgrade
|
P/TBV Ratio | 1.92 | 2.13 | 2.21 | 2.09 | 3.41 | 2.19 | Upgrade
|
P/FCF Ratio | 16.87 | 18.70 | 7.78 | 29.06 | 18.29 | 7.26 | Upgrade
|
P/OCF Ratio | 16.33 | 18.09 | 7.38 | 27.60 | 17.81 | 7.17 | Upgrade
|
EV/Sales Ratio | 0.91 | 1.06 | 1.06 | 0.93 | 1.57 | 0.93 | Upgrade
|
EV/EBITDA Ratio | 5.91 | 7.01 | 6.40 | 5.66 | 7.95 | 5.52 | Upgrade
|
EV/EBIT Ratio | 6.21 | 7.20 | 6.53 | 5.79 | 8.11 | 5.70 | Upgrade
|
EV/FCF Ratio | 12.14 | 14.10 | 6.29 | 23.57 | 15.58 | 5.79 | Upgrade
|
Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.09 | Upgrade
|
Debt / EBITDA Ratio | 0.04 | 0.04 | 0.03 | 0.05 | 0.03 | 0.26 | Upgrade
|
Debt / FCF Ratio | 0.09 | 0.09 | 0.03 | 0.23 | 0.07 | 0.28 | Upgrade
|
Asset Turnover | 1.21 | 1.21 | 1.32 | 1.38 | 1.35 | 1.23 | Upgrade
|
Inventory Turnover | 2.33 | 2.33 | 2.34 | 2.03 | 2.42 | 2.47 | Upgrade
|
Quick Ratio | 2.11 | 2.11 | 2.21 | 1.66 | 1.59 | 1.64 | Upgrade
|
Current Ratio | 3.06 | 3.06 | 2.98 | 2.77 | 2.43 | 2.24 | Upgrade
|
Return on Equity (ROE) | 18.36% | 18.36% | 22.74% | 21.94% | 30.06% | 24.96% | Upgrade
|
Return on Assets (ROA) | 11.06% | 11.06% | 13.30% | 13.82% | 16.32% | 12.51% | Upgrade
|
Return on Capital (ROIC) | 15.10% | 15.10% | 18.37% | 19.75% | 24.02% | 18.41% | Upgrade
|
Return on Capital Employed (ROCE) | 22.20% | 22.20% | 27.20% | 29.00% | 35.80% | 29.00% | Upgrade
|
Earnings Yield | 8.74% | 7.89% | 9.47% | 9.25% | 7.91% | 11.27% | Upgrade
|
FCF Yield | 5.93% | 5.35% | 12.86% | 3.44% | 5.47% | 13.78% | Upgrade
|
Dividend Yield | 5.71% | 5.17% | 5.45% | 4.96% | 3.49% | 5.14% | Upgrade
|
Payout Ratio | 58.85% | 58.85% | 37.08% | 42.88% | 34.91% | 32.38% | Upgrade
|
Buyback Yield / Dilution | -1.70% | -1.70% | -1.30% | -1.64% | -0.97% | 3.93% | Upgrade
|
Total Shareholder Return | 4.02% | 3.48% | 4.15% | 3.32% | 2.53% | 9.06% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.